149 related articles for article (PubMed ID: 29240642)
1. Body Mass's Impact on Response to Fixed-Dose Vasopressin in Patients With Septic Shock.
Torbic H; Sacha GL; Bauer SR; Lam SW
Shock; 2018 Oct; 50(4):388-394. PubMed ID: 29240642
[TBL] [Abstract][Full Text] [Related]
2. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
3. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
Lam SW; Bauer SR; Cha SS; Oyen LJ
Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
[TBL] [Abstract][Full Text] [Related]
4. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
5. Predictors of response to fixed-dose vasopressin in adult patients with septic shock.
Sacha GL; Lam SW; Duggal A; Torbic H; Bass SN; Welch SC; Butler RS; Bauer SR
Ann Intensive Care; 2018 Mar; 8(1):35. PubMed ID: 29511951
[TBL] [Abstract][Full Text] [Related]
6. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
Miller JT; Welage LS; Kraft MD; Alaniz C
J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
[TBL] [Abstract][Full Text] [Related]
7. Effect of Vasopressin Dose on Hemodynamic Response in Obese Patients With Septic Shock: A Retrospective Observational Study.
Dubrawka CA; Betthauser KD; Pope HE; Gibson GA
Ann Pharmacother; 2021 Dec; 55(12):1447-1454. PubMed ID: 33813908
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
9. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
10. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
11. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
[TBL] [Abstract][Full Text] [Related]
12. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
13. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
Jakowenko ND; Murata J; Kopp BJ; Erstad BL
J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
[No Abstract] [Full Text] [Related]
14. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
[TBL] [Abstract][Full Text] [Related]
15. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.
Yerke JR; Sacha GL; Scheraga RG; Culver DA; Abraham S; Torbic H; Lam SW; Ammar MA; Olman MA; Bauer SR
Pharmacotherapy; 2020 Jan; 40(1):33-39. PubMed ID: 31705703
[TBL] [Abstract][Full Text] [Related]
17. Early vasopressin reduces incidence of new onset arrhythmias.
Reardon DP; DeGrado JR; Anger KE; Szumita PM
J Crit Care; 2014 Aug; 29(4):482-5. PubMed ID: 24747036
[TBL] [Abstract][Full Text] [Related]
18. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin Response and Clinical Trajectory in Septic Shock Patients.
Bauer SR; Sacha GL; Siuba MT; Wang L; Wang X; Scheraga RG; Vachharajani V
J Intensive Care Med; 2023 Mar; 38(3):273-279. PubMed ID: 36062611
[TBL] [Abstract][Full Text] [Related]
20. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
Buckley MS; MacLaren R
J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
